By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences today amended its preliminary prospectus, increasing the amount it hopes to raise from its initial public offering to up to $230 million.

The company had said that the offering could raise as much as $200 million in its original Form S-1 filed in August.

The firm still has not priced its shares for the proposed IPO.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.